USE OF AN ANTIBODY AND A PARTICULATE IMMUNOMODULATOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14470434

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The current invention is directed to particulate or vesicular immunomodulators, like e.g. cytokines, for use in combination therapy with antibodies for treatments of a range of conditions and diseases, in particular cancer, as well as methods, compositions, and kits thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE CLAUDE BERNARD LYON I43 BOULEVARD DU 11 NOVEMBRE 1918 VILLEURBANNE CEDEX 69622
HOSPICES CIVILS DE LYON3 QUAI DES CELESTINS LYON CEDEX 2 69229
EPITARGET ASP O BOX 7159 MAJORSTUEN OSLO NO-0307

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DUMONTET, Charles Lyon, FR 14 44
NILSSEN, Esben A Oslo, NO 10 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation